Pacira BioSciences, Inc. (NASDAQ:PCRX)
Industry: Healthcare

OFF LIST - 797 consecutive market days: OFF LIST as of 04/05/2013 Through 11/14/2016

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is based in Parsippany, New Jersey.

Current Quote*
Last: $43.575
Change: -0.045
Book: $5.468
Volume: 130,208

As Of: 05/24 13:16 ET
*Quotes delayed by 20min.

Graphs for PCRX

3 Month Graph

6 Month Graph

1 Year Graph